https://www.selleckchem.com/products/otssp167.html
rovement among participants receiving the intervention during the first year. Participant enrollment began in March 2017. We have recruited 221 patients. Intervention delivery and data collection will continue until November 2021. The results are expected to be published by May 2022. This is among the first trials to incorporate health coaches, clinical pharmacists, and mHealth technologies to increase access to diabetes support among urban African-Americans and Latinos to achieve therapeutic goals. DERR1-10.2196/17170. DERR1-10.2196/1
Beğen
Yorum Yap
Paylaş
